Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 12 years
- Director since
- 2023
12 years of board service in total across 4 boards, counting each seat separately. Longest: X4 Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Neurogene Inc. December 13, 20230.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 24, 2026 | Scholar Rock Holding Corporation | Gift | −48,034 | — | — |
| Apr 16, 2026 | Scholar Rock Holding Corporation | Open-market sale | −10,220 | $49.57 | $506,605 |
| Feb 9, 2026 | Scholar Rock Holding Corporation | Grant or award | +47,021 | — | — |
| Jan 13, 2026 | Scholar Rock Holding Corporation | Open-market sale | −16,746 | $42.70 | $715,054 |
| Jun 9, 2025 | X4 Pharmaceuticals Inc. | Grant or award | +1,500 | — | — |
| Apr 27, 2025 | Scholar Rock Holding Corporation | Grant or award | +100,000 | — | — |
| Apr 27, 2025 | Scholar Rock Holding Corporation | Grant or award | +500,000 | — | — |
| Jun 10, 2024 | X4 Pharmaceuticals Inc. | Grant or award | +45,000 | — | — |
| Oct 16, 2023 | X4 Pharmaceuticals Inc. | Grant or award | +90,000 | — | — |
Questions about Keith Woods
What boards is Keith Woods on?
Keith Woods sits on the boards of Neurogene Inc., Rocket Pharmaceuticals Inc., TScan Therapeutics Inc. and X4 Pharmaceuticals Inc.
How long has Keith Woods served on boards?
Our records show at least 12 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.